Exercise for depression could reshape mental-health care

Exercise for depression has evidence behind it, yet limited clinician training keeps structured activity outside routine mental-health care. The debate is less about whether movement can help than whether health systems know how to prescribe it.

In a July 21, 2026 essay, Nicholas Fabiano, M.D., argued that exercise should be treated with the same seriousness as medication or psychotherapy in depression care. His case rests on a gap between clinical research, treatment guidelines and what patients often hear in appointments.

Depression care leaves patients short

Fabiano wrote that an estimated 1.17 billion people worldwide live with a mental disorder, with depression among the most common conditions. He also pointed to the higher risk of obesity, diabetes and heart disease among people with depression, making the physical side of care clinically relevant rather than optional.

The current default remains medication, therapy or both, but Fabiano cited evidence that 30% to 50% of patients do not see meaningful improvement. That leaves a large group for whom additional tools matter, especially if they also address health risks that talk therapy and antidepressants do not directly target.

The clinical case is not built on one study. Fabiano wrote that hundreds of trials have found exercise can reduce depressive symptoms, with effects in mild to moderate cases generally comparable to medication or therapy.

He also cited research linking half of the . When added to medication or therapy, exercise may have additive effects, according to the evidence he summarized.

The mechanisms are broader than mood alone. Fabiano described exercise as acting through brain-derived neurotrophic factor, hippocampal neuroplasticity, lower chronic inflammation, stress-response regulation, self-esteem, self-efficacy and social connection.

FITT turns exercise into dosing

The implementation problem is stark. Fabiano wrote that exercise is already .

That gap changes the quality of care. A medication plan usually includes a drug name, dose, duration and side-effect warnings, while exercise advice is often reduced to a broad suggestion to work out.

Fabiano pointed to the FITT framework as a practical fix: frequency, intensity, type and time. A structured starting point could be brisk walking three times a week for 20 to 30 minutes at an effort level that still allows conversation.

The barrier is not only professional training. Depression itself can bring fatigue and low motivation, so Fabiano argued that programs may need to begin very small, include supervision or social support, and work alongside established treatments rather than replace them.

CANMAT work signals a shift

Fabiano said he is leading new recommendations from the Canadian Network for Mood and Anxiety Treatments and the International Society for Bipolar Disorders on exercise in depression and bipolar disorder. If adopted widely, that work could give clinicians a clearer pathway for turning research into routine care.

Health systems would still need infrastructure. Referral routes to qualified exercise professionals, insurance coverage for supervised programs and practical clinician education would determine whether exercise becomes a repeatable intervention or remains a well-supported idea with uneven delivery.

If structured exercise prescribing gains traction, the macro effect would come through prevention, comorbidity reduction and lower pressure on mental-health services. For clinicians and guideline groups, success would mean translating evidence into usable protocols; for gyms, physiotherapists and exercise professionals, it could create a more formal role in behavioral health.

If the current pattern holds, patients may continue receiving uneven advice despite favorable evidence. The main risks are overhyping exercise as superior to established treatments, underestimating depression-related barriers and failing to pay for the supervision that makes a program realistic.